Sunday, April 26, 2009: 8:00 AM-9:30 AM
Session Organizer:
Emma Webb, ACCP
Assessment of subcutaneous absorption of enoxaparin for deep vein thrombosis prophylaxis using anti-factor Xa level measurements in non-critically-ill mechanically-ventilated patients
Angela O. Shogbon, Pharm.D., Mercer University College of Pharmacy and Health Sciences;
Steven B. Levy, Pharm.D., BCPS, CGP, Kingsbrook Jewish Medical Center;
Wilfrid Herard, MD, Kingsbrook Jewish Medical Center;
Maria Arias, RNC, BSN, Kingsbrook Jewish Medical Center;
Henry Cohen, MS, Pharm.D., FCCM, BCPP, CGP, Arnold & Marie Schwartz College of Pharmacy and Health Sciences of Long Island University and Kingsbrook Jewish Medical Center
Preparation of pharmacy clerkship students for advanced pharmacy practice experiences
Kellie L. Bennett, PharmD, BCPS, Sullivan University College of Pharmacy;
Amy Lullo, RPh, Midwester University, Chicago College of Pharmacy;
Susan Cornell, PharmD, CDE, Midwester University, Chicago College of Pharmacy
Therapeutic education for stroke hypertensive patients: preliminary results of a pilot study
Beaussier Hélène, Ms, Department of Pharmacy Groupe Hospitalier Paris Saint Joseph;
Rouault Anne, Dr, Department of Pharmacy Groupe Hospitalier Paris Saint Joseph;
Houot Mélanie, Ms, Department of Pharmacy Groupe Hospitalier Paris Saint Joseph;
Bézie Yvonnick, Dr, Department of Pharmacy Groupe Hospitalier Paris Saint Joseph;
Zuber Mathieu, Pr, Department of Neurology Groupe Hospitalier Paris Saint Joseph
Impact of a student-supported pharmacy assessment program on venous thromboembolism assessment and prophylaxis rates in hospitalized patients
Laura E. Butkievich, Pharm.D., University of Missouri Hospital and Clinics;
Zachary A. Stacy, Pharm.D., BCPS, St. Louis College of Pharmacy;
Michael W. Daly, Pharm.D., BCPS, St. Louis College of Pharmacy;
Way Y. Huey, Pharm.D., FCCM, BCPS, St. Luke's Hospital;
Charles T. Taylor, Pharm.D., BCPS, University of Minnesota College of Pharmacy
Protective effects of Nigella sativa oil on antituberculous drug combination- induced hepatotoxicity in rats
Nur Sener, M.Sc, Marmara University Faculty of Pharmacy, Biochemistry Department;
Fikret V. Izzettin, Prof., Marmara University Faculty of Pharmacy, Clinical Pharmacy Department;
Ozlem Ozakpinar, M.Sc, Marmara University Faculty of Pharmacy, Biochemistry Department;
Murat B. Rabus, M.D., Kosuyolu Heart and Research Hospital, Cardiovascular Surgery Department;
Betül Okuyan, MSc, Marmara University Faculty of Pharmacy, Clinical Pharmacy Department;
Mesut Sancar, Ph.D., Marmara University Faculty of Pharmacy, Clinical Pharmacy Department;
Elcin Yorukoglu, Pharm, Marmara University Faculty of Pharmacy, Clinical Pharmacy Department;
Fikriye Uras, Prof, Marmara University Faculty of Pharmacy, Biochemistry Department
Improving accessibility, effectiveness, safety and work life with pharmacy technician on the patient care units
T.H. Diem Vo, B.Pharm., M.Sc., MBA, McGill University Health Centre;
Alain Biron, N. PhD(c), McGill University Health Centre;
Patricia Lefebvre, B. Pharm., M. Sc., FCSHP, McGill University Health Centre;
Linda Ward, M. Sc. (A), McGill University Health Centre
Compounding Project: Calcium Levofolinate
Anna Bianca Calzona, PHARMACY, Sandro Pertini Hospital;
Daniela Checquolo, PHARMACY, Sandro Pertini Hospital;
Simona Ferraiuolo, PHARMACY, Sandro Pertini Hospital;
Giovanni Guarany, PHARMACY, Sandro Pertini Hospital;
Gerardo Miceli Sopo, PHARMACY, Sandro Pertini Hospital;
Grazia Mingolla, PHARMACY, Sandro Pertini Hospital;
Roberto Tazza, PHARMACY, Sandro Pertini Hospital
HEALTH Technology Assessment:Trastuzumab
Anna Bianca Calzona, PHARMACY, Sandro Pertini Hospital;
Daniela Checquolo, PHARMACY, Sandro Pertini Hospital;
Rossella Distillo, PHARMACY, Sandro Pertini Hospital;
Simona Ferriuolo, PHARMACY, Sandro Pertini Hospital;
Giovanni Guarany, PHARMACY, Sandro Pertini Hospital;
Gerardo Miceli Sopo, PHARMACY, Sandro Pertini Hospital;
Grazia Mingolla, PHARMACY, Sandro Pertini Hospital;
Daniela Scolaro, PHARMACY, Sandro Pertini Hospital;
Roberto Tazza, PHARMACY, Sandro Pertini Hospital
Efficacy and safety of omalizumab added to optimized asthma care in children with inadequately controlled allergic asthma
B. Lanier Jr., MD, University of North Texas;
T. Bridges, MD, Georgia Pollens Clinical Research Centers Inc;
M. Kulus, MD, Medical University of Warsaw;
A. FowlerTaylor, RPh, Novartis Pharmaceuticals Corporation;
M. Blogg, MD, Novartis Horsham Research Centre;
R. Maykut, MD, Novartis Pharmaceuticals Corporation;
M. Massanari, PharmD, Novartis Pharmaceuticals Corporation;
P. Jimenez, MD, Novartis Pharmaceuticals Corporation
Quality of life assessment in diabetic patients attending outpatient clinic in a tertiary health care facility
Ehijie Enato, PhD, Department of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, University of Benin;
Ephraim Ekweanua, PharmD, Federal Medical Center, Asaba;
Azuka C. Oparah, PhD, Department of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, University of Benin;
Michael E. Arigbe-Osula, PharmD, Department of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, University of Benin;
Ochuwa E. Aghomo, MPharm, Department of Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, University of Benin
Effects of omeprazole on the pharmacokinetic profiles of lisdexamfetamine dimesylate and extended-release mixed amphetamine salts in adults
Mary Haffey, RPh, Shire Development Inc.;
Mary Buckwalter, MS, Shire Development Inc.;
Pinggao Zhang, PhD, Shire Development Inc.;
Robert Homolka, MS, Shire Development Inc.;
Patrick Martin, MD, Shire Development Inc.;
Ken Lasseter, MD, Shire Development Inc.;
James Ermer, MS, Shire Development Inc.
![[ Visit Client Website ]](images/banner.gif)